Evidence map›Paper›PMID 28522367›Full record

ArticleHeart rhythm2017

QRS/T-wave and calcium alternans in a type I diabetic mouse model for spontaneous postmyocardial infarction ventricular tachycardia: A mechanism for the antiarrhythmic effect of statins.

Hongwei Jin, Charles M Welzig, Mark Aronovitz, Farzad Noubary, Robert Blanton, Bo Wang, Mohammad Rajab, Alfred Albano, Mark S Link, Sami F Noujaim and 2 more

Open access · greenAbstract read
In one paragraph

Article in Heart rhythm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. In vitro and in vivo cardiac toxicity of flavored electronic nicotine delivery systems.American journal of physiology. Heart and circulatory physiology · 2021
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Hongwei JinTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts. Electronic address: HJin@tuftsmedicalcenter.org.
Charles M WelzigTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Departments of Neurology, Physiology and Biomedical Engineering, Medical College of Wisconsin, Milwaukee, Wisconsin.
Mark AronovitzTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts.
Farzad NoubaryTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Tufts Clinical and Translational Science Institute, Boston, Massachusetts.
Robert BlantonTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts; Cardiovascular Division, Cardiovascular Center, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.
Bo WangTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts.
Mohammad RajabMolecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts; Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia.
Alfred AlbanoTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts; Spectrum Health, Grand Rapids, Michigan.
Mark S LinkTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Tufts Clinical and Translational Science Institute, Boston, Massachusetts; UT Southwestern Medical Center, Dallas, Texas.
Sami F NoujaimTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, Tampa, Florida.
Ho-Jin ParkTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts. Electronic address: HPark@tuftsmedicalcenter.org.
Jonas B GalperTufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts; Cardiovascular Division, Cardiovascular Center, Department of Medicine, Tufts Medical Center, Boston, Massachusetts. Electronic address: JGalper@tuftsmedicalcenter.org.
Tufts University · USTufts Medical Center · USCorewell Health Blodgett Hospital · USMedical College of Wisconsin · USSouthern California Clinical and Translational Science Institute · USVirginia Commonwealth University Medical Center · US

Funding

Tufts Clinical and Translational Research InstituteUL1TR001064 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2013 to 2017
$26.4M
Role of Sterols &Insulin in Cardiac Autonomic ResponseR01HL074876 · NHLBI · TUFTS MEDICAL CENTER · PI GALPER, JONAS BERNARD · 2004 to 2013
$3.2M
An Animal Model of Diabetic Autonomic Neuropathy: Study of Mechanism and TherapyR01HL087827 · NHLBI · TUFTS MEDICAL CENTER · PI GALPER, JONAS BERNARD · 2007 to 2010
$2.3M
Molecular Mechanisms for Atrial Fibrillation in AgingR01HL129136 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI NOUJAIM, SAMI FOUAD · 2015 to 2019
$2.0M
A Molecular Marker for Cardiac Autonomic DysfunctionR21DK079622 · NIDDK · TUFTS MEDICAL CENTER · PI PARK, HO-JIN · 2007 to 2008
$403k
NCATS NIH HHS UL1 TR001064NHLBI NIH HHS R01 HL074876NHLBI NIH HHS R01 HL087827NHLBI NIH HHS R01 HL129136NIDDK NIH HHS R21 DK079622
6 · The paper itself

Abstract

backgroundThe incidence of sudden arrhythmic death is markedly increased in diabetics.

objectiveThe purpose of this study was to develop a mouse model for postmyocardial infarction (post-MI) ventricular tachycardia (VT) in the diabetic heart and determine the mechanism of an antiarrhythmic effect of statins.

methodsECG transmitters were implanted in wild-type (WT), placebo, and pravastatin-treated type I diabetic Akita mice. MIs were induced by coronary ligation, and Ca

resultsBurst pacing of Akita mouse hearts resulted in rate-related QRS/T-wave alternans, which was attenuated in pravastatin-treated mice. Post-MI Akita mice developed QRS/T-wave alternans and VT at 2820 ± 879 beats per mouse, which decreased to 343 ± 115 in pravastatin-treated mice (n = 13, P <.05). Optical mapping demonstrated pacing-induced VT originating in the peri-infarction zone and Ca

conclusionPravastatin decreased the incidence of post-MI VT and Ca

Indexed as

Diabetes Mellitus, ExperimentalElectrocardiographyAnimalsCalciumDiabetes Mellitus, Type 1Heart VentriclesHydroxymethylglutaryl-CoA Reductase InhibitorsMiceMice, Inbred C57BLMyocardial InfarctionTachycardia, VentricularCalciumHydroxymethylglutaryl-CoA Reductase InhibitorsAkita mouseCa(2+) alternansCa(2+) handling proteinsDiabetesMyocardial infarctionQRS/T-wave alternansStatinsVentricular tachycardia

Identifiers

PMID28522367
PMCPMC5713915
OpenAlexW2614445230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.